Clinical APIs are active pharmaceutical ingredients intended for use in human clinical development, typically before a drug receives full marketing approval. They are usually manufactured under controlled GMP or phase-appropriate GMP conditions and supplied for formulation into clinical trial drug products used in Phase I, II, or III studies.
